FDA RecallsZantac Heatburn Medication

The Food & Drug Administration (FDA) announced yesterday that they are recalling all over the counter and prescription rantidine drugs, which is known by the brand name Zantac. This also includes all generic versions of the drug. Importantly, the FDA advised consumers to stop taking any ranitidine tablets or liquid medications they currently have. 

The FDA announced in their recall that an ongoing study revealed

that levels of a contaminant in the heartburn medications increase over time and when stored at higher-than-normal temperatures, pose a risk to public health.The contaminant, N-nitrosodimethylamine or NDMA, is a probable human carcinogen and the FDA has been investigating levels of it in ranitidine since the summer of 2019. In short, studies have shown that prolonged used of Zantac (and its’ generic version) could cause certain forms of cancer.

If you have Zantac in you medicine cabinate, please stop taking it and throw it away immediately. If you believe you have a cancer diagnosis that could be linked to long term use of Zantac, then call Chicago personal injury attorney, Aaron J. Bryant, for a free legal consultation at 312-614-1076.